Effects of Triiodothyronine on Cell Proliferation in Kidney Cancer
Author Information
Author(s): Piotr Poplawski, Alicja Nauman
Primary Institution: Department of Biochemistry and Molecular Biology, The Medical Centre of Postgraduate Education, Warsaw, Poland
Hypothesis
How does triiodothyronine affect the proliferation of human proximal tubule and renal cancer cell lines?
Conclusion
Triiodothyronine inhibits proliferation in HK2 cells while stimulating it in Caki-2 and Caki-1 cells due to differences in receptor expression.
Supporting Evidence
- T3 inhibits proliferation of HK2 cells and stimulates it in Caki-2 and Caki-1 cells.
- Proliferation differences are linked to the expression of thyroid hormone receptors and cell cycle regulators.
- Lower levels of E2F4 in cancer cells correlate with faster proliferation.
Takeaway
Triiodothyronine can either help or hurt cell growth depending on the type of kidney cells, making it important for understanding kidney cancer.
Methodology
Cell counting, cytometric analysis of DNA content, western blot, and semi-quantitative real-time PCR were used to assess the effects of T3 on cell proliferation and gene expression.
Limitations
The study primarily focuses on in vitro cell lines, which may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website